Every patient undergoing ovulation stimulation is at risk of developing ovarian hyperstimulation syndrome (OHSS). The most significant risk factor for OHSS is polycystic ovarian syndrome (PCOS). The degree of the follicular response to the ovulation-stimulating drugs is related to the severity of OHSS. Join us for an exclusive webinar to get insights on ovarian hyperstimulation syndrome with expert Gynecologist Dr. Ameet Patki on 1 st March 2025 , from 2:00 PM IST onwards.
Stay tuned! Suggested readings What are the Risks Associated with Double-embryo Transfer in ART? Elevated Suicide Risk Among Individuals with Polycystic Ovary Syndrome ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data…
